Market Tracker

07/24 6:24am ET

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

3.13
Data as of Jul 23
 +0.04 / +1.29%
Today’s Change
2.75
Today|||52-Week Range
5.50
-22.14%
Year-to-Date
No recent news for Cyclacel Pharmaceuticals Inc.

Today’s Trading

Previous close3.09
Today’s open3.10
Day’s range-- - --
Volume44,573
Average volume (3 months)135,558
Market cap$70.1M
Dividend yield--
Data as of 07/23/2014

Growth & Valuation

Earnings growth (last year)+23.81%
Earnings growth (this year)+16.15%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,471.01%
P/E ratioNM
Price/Sales56.21
Price/Book2.14

Competitors

 Today’s
change
Today’s
% change
HSKAHeska Corp+0.14+1.26%
OGENOragenics Inc-0.01-0.51%
MSTXMast Therapeutics In...+0.01+1.67%
CNDOCoronado Biosciences...+0.04+2.44%
Data as of 07/23/2014

Financials

Next reporting dateAugust 7, 2014
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$1.1M
Annual profit (last year)-$10.2M
Net profit margin-941.88%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Spiro Rombotis
COO, CFO, Secretary, Director &
Executive VP
Paul McBarron
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts